Investigation of the prognostic significance of c-kit and c-erb-b2 expression in osteosarcoma, ewing sarcoma, and rhabdomyosarcoma and comparison with clinical parameters
dc.contributor.author | Aydogdu, Gulay | |
dc.contributor.author | Bilgic, Bilge | |
dc.contributor.author | Kiroglu, Kumru | |
dc.date.accessioned | 2024-04-24T17:20:46Z | |
dc.date.available | 2024-04-24T17:20:46Z | |
dc.date.issued | 2023 | |
dc.department | Dicle Üniversitesi | en_US |
dc.description.abstract | Objective: In the present study, the prognostic and treatment-guiding roles of the c-erb-B2 oncoprotein and tyrosine kinase receptor c-kit in osteosarcoma (OS), Ewing sarcoma (ES), and rhabdomyosarcoma (RMS) were evaluated. Materials and methods: With 25 cases from each group, c-kit and c-erb-B2 expression were investigated immunohistochemically in a total of 75 cases. Results: Staining for c-kit was found to be positive in 15 (60%) of the RMS, 11 of the OS (44%), and 11 of the ES cases (44%). C-erbB-2 staining was positive in 7 RMS cases (8%) and negative in all cases of OS and ES.The SISH method was applied to six c-erb-B2 positive RMS cases, and amplification of the HER2 gene (encoding c-erb-B2) was detected in one case. It was determined that c-kit expression in OS was significantly associated with survival (p<0.05) and could be considered as a poor prognostic parameter. In contrast,c-kit expression had no prognostic significance in ES and RMS. In the RMS group, there was no relationship between c-erb-B2 positivity and prognosis. Conclusion: It was concluded that c-kit expression can be used as a poor prognostic parameter for OS and therapy targeting c-kit may be an alternative treatment option. | en_US |
dc.identifier.doi | 10.3306/AJHS.2023.38.05.77 | |
dc.identifier.endpage | 83 | en_US |
dc.identifier.issn | 1579-5853 | |
dc.identifier.issn | 2255-0569 | |
dc.identifier.issue | 5 | en_US |
dc.identifier.startpage | 77 | en_US |
dc.identifier.uri | https://doi.org/10.3306/AJHS.2023.38.05.77 | |
dc.identifier.uri | https://hdl.handle.net/11468/19236 | |
dc.identifier.volume | 38 | en_US |
dc.identifier.wos | WOS:001106456700012 | |
dc.identifier.wosquality | N/A | |
dc.indekslendigikaynak | Web of Science | |
dc.language.iso | en | en_US |
dc.publisher | Reial Acad Medicina Illes Balears | en_US |
dc.relation.ispartof | Medicina Balear | |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.subject | Osteosarcoma | en_US |
dc.subject | Ewing Sarcoma | en_US |
dc.subject | Rhabdomyosarcoma | en_US |
dc.subject | C-Kit | en_US |
dc.subject | C-Erb-B2 | en_US |
dc.title | Investigation of the prognostic significance of c-kit and c-erb-b2 expression in osteosarcoma, ewing sarcoma, and rhabdomyosarcoma and comparison with clinical parameters | en_US |
dc.title | Investigation of the prognostic significance of c-kit and c-erb-b2 expression in osteosarcoma, ewing sarcoma, and rhabdomyosarcoma and comparison with clinical parameters | |
dc.type | Article | en_US |